Cargando…
Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria
OBJECTIVE: Candida auris is a globally emerging pathogen associated with significant mortality. This pathogen frequently is misidentified by traditional biochemical methods and is resistant to commonly used antifungals. The echinocandins currently are recommended as the first-line treatment for C. a...
Autores principales: | Biagi, Mark J, Wiederhold, Nathan P, Gibas, Connie, Wickes, Brian L, Lozano, Victoria, Bleasdale, Susan C, Danziger, Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602379/ https://www.ncbi.nlm.nih.gov/pubmed/31281859 http://dx.doi.org/10.1093/ofid/ofz262 |
Ejemplares similares
-
Candida auris Candidemia in Kuwait, 2014
por: Emara, Maha, et al.
Publicado: (2015) -
Echinocandins as Biotechnological Tools for Treating Candida auris Infections
por: Cândido, Elizabete de Souza, et al.
Publicado: (2020) -
Candida auris–Associated Candidemia, South Africa
por: Magobo, Rindidzani E., et al.
Publicado: (2014) -
In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against Candida auris
por: Caballero, Unai, et al.
Publicado: (2021) -
Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016)